Market Performance: A Measured Yet Positive Debut
The Nephrocare Health IPO listing today opened on a steady note, delivering a modest premium for investors on debut. The stock entered the secondary market with gains, reflecting the healthy demand built during the IPO bidding phase.
On the listing day, the Nephrocare Health share price opened at:
- ₹490 on NSE
- ₹491 on BSE
This marked a gain of 6.89% over the IPO issue price of ₹460, giving the listing a calm but positive start without sharp volatility.
Main News: How the Listing Played Out
The Nephrocare Health IPO listing took place on Wednesday, December 17, following the completion of the allotment process earlier in the week. The stock’s entry at a premium highlighted steady investor participation across exchanges.
The difference in opening prices between NSE and BSE remained marginal, indicating balanced demand on both platforms. The listing performance stayed aligned with the overall response the IPO received during its bidding window.
IPO Details: Strong Subscription Numbers
The Nephrocare Health IPO saw robust demand during the subscription period. By the final day of bidding, the issue was subscribed 13.96 times.
Subscription data showed strong participation across categories:
- Total bids received: 18.69 crore shares
- Shares on offer: 1.34 crore
- Qualified Institutional Buyers (QIBs): 27.47 times
- Non-Institutional Investors (NIIs): 24.27 times
- Retail investors: 2.31 times
The IPO was structured as a book-built issue, combining a fresh issue and an offer-for-sale, with the aim of raising approximately ₹871 crore.
Price Band, Lot Size, and Key Dates
The Nephrocare Health IPO price band was fixed at ₹438–₹460 per share.
- Lot size: 32 shares
- IPO allotment date: December 15, 2025
- IPO listing date: December 17, 2025
These timelines followed the standard mainboard IPO schedule, with shares credited shortly before listing.
Use of IPO Proceeds
As outlined in the offer documents, the company plans to utilise the IPO proceeds for:
- Expansion of its dialysis clinic network across India
- Reduction of outstanding debt
- General corporate purposes
Company Details: What Nephrocare Health Does
Nephrocare Health operates in the healthcare space, focusing on dialysis and renal care services. The company has built a strong footprint across Tier-2 and Tier-3 cities, supported by strategic partnerships and an asset-light business model.
Its clinic network spans multiple locations across India, along with a presence in select international markets. The company’s approach has allowed it to scale services while maintaining operational flexibility.
Summary: A Stable Start for Nephrocare Health
The Nephrocare Health IPO listing delivered a measured debut, with shares opening nearly 7% higher than the issue price on both NSE and BSE. Strong subscription numbers across investor categories supported the listing, even as price gains remained controlled.
Overall, the debut reflected steady market sentiment, where investors responded positively to the offering without pushing prices into sharp post-listing swings. The listing added another data point to ongoing IPO listing news, highlighting disciplined participation in the primary and secondary markets.
Easy & quick
Leave A Comment?